vs
HAVERTY FURNITURE COMPANIES INC（HVT）与Orthofix Medical Inc.（OFIX）财务数据对比。点击上方公司名可切换其他公司
Orthofix Medical Inc.的季度营收约是HAVERTY FURNITURE COMPANIES INC的1.1倍（$219.9M vs $201.9M），HAVERTY FURNITURE COMPANIES INC净利率更高（4.2% vs -1.0%，领先5.2%），HAVERTY FURNITURE COMPANIES INC同比增速更快（9.5% vs 2.0%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $3.0M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs 4.8%）
该企业原名为国际鞋业公司，1911年由两家鞋企合并成立于美国密苏里州克莱顿，后开展多元化业务并逐步退出制鞋领域，最终更名为家具品牌国际，是美国家居行业知名企业，曾拥有布罗伊希尔等多个知名家具品牌。
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
HVT vs OFIX — 直观对比
营收规模更大
OFIX
是对方的1.1倍
$201.9M
营收增速更快
HVT
高出7.6%
2.0%
净利率更高
HVT
高出5.2%
-1.0%
自由现金流更多
OFIX
多$13.9M
$3.0M
两年增速更快
OFIX
近两年复合增速
4.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $201.9M | $219.9M |
| 净利润 | $8.5M | $-2.2M |
| 毛利率 | 60.4% | 71.1% |
| 营业利润率 | 5.3% | 0.2% |
| 净利率 | 4.2% | -1.0% |
| 营收同比 | 9.5% | 2.0% |
| 净利润同比 | 4.1% | 92.4% |
| 每股收益（稀释后） | — | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HVTOFIX
| Q4 25 | $201.9M | $219.9M | ||
| Q3 25 | $194.5M | $205.6M | ||
| Q2 25 | $181.0M | $203.1M | ||
| Q1 25 | $181.6M | $193.6M | ||
| Q4 24 | $184.4M | $215.7M | ||
| Q3 24 | $175.9M | $196.6M | ||
| Q2 24 | $178.6M | $198.6M | ||
| Q1 24 | $184.0M | $188.6M |
净利润HVTOFIX
| Q4 25 | $8.5M | $-2.2M | ||
| Q3 25 | $4.7M | $-22.8M | ||
| Q2 25 | $2.7M | $-14.1M | ||
| Q1 25 | $3.8M | $-53.1M | ||
| Q4 24 | $8.2M | $-29.1M | ||
| Q3 24 | $4.9M | $-27.4M | ||
| Q2 24 | $4.4M | $-33.4M | ||
| Q1 24 | $2.4M | $-36.0M |
毛利率HVTOFIX
| Q4 25 | 60.4% | 71.1% | ||
| Q3 25 | 60.3% | 72.2% | ||
| Q2 25 | 60.8% | 68.7% | ||
| Q1 25 | 61.2% | 62.8% | ||
| Q4 24 | 61.9% | 69.0% | ||
| Q3 24 | 60.2% | 68.7% | ||
| Q2 24 | 60.4% | 67.8% | ||
| Q1 24 | 60.3% | 67.5% |
营业利润率HVTOFIX
| Q4 25 | 5.3% | 0.2% | ||
| Q3 25 | 3.3% | -8.3% | ||
| Q2 25 | 2.4% | -7.9% | ||
| Q1 25 | 2.9% | -25.2% | ||
| Q4 24 | 5.2% | -5.3% | ||
| Q3 24 | 3.9% | -9.6% | ||
| Q2 24 | 3.6% | -12.5% | ||
| Q1 24 | 1.7% | -15.6% |
净利率HVTOFIX
| Q4 25 | 4.2% | -1.0% | ||
| Q3 25 | 2.4% | -11.1% | ||
| Q2 25 | 1.5% | -6.9% | ||
| Q1 25 | 2.1% | -27.4% | ||
| Q4 24 | 4.4% | -13.5% | ||
| Q3 24 | 2.8% | -13.9% | ||
| Q2 24 | 2.5% | -16.8% | ||
| Q1 24 | 1.3% | -19.1% |
每股收益（稀释后）HVTOFIX
| Q4 25 | — | $-0.05 | ||
| Q3 25 | — | $-0.57 | ||
| Q2 25 | — | $-0.36 | ||
| Q1 25 | — | $-1.35 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.71 | ||
| Q2 24 | — | $-0.88 | ||
| Q1 24 | — | $-0.95 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $125.3M | $82.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $307.9M | $450.0M |
| 总资产 | $649.1M | $850.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资HVTOFIX
| Q4 25 | $125.3M | $82.0M | ||
| Q3 25 | $130.5M | $62.9M | ||
| Q2 25 | $107.4M | $65.6M | ||
| Q1 25 | $111.9M | $58.0M | ||
| Q4 24 | $120.0M | $83.2M | ||
| Q3 24 | $121.2M | $30.1M | ||
| Q2 24 | $109.9M | $26.4M | ||
| Q1 24 | $111.8M | $27.0M |
总债务HVTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | $157.2M | ||
| Q2 25 | — | $157.0M | ||
| Q1 25 | — | $156.9M | ||
| Q4 24 | — | $157.0M | ||
| Q3 24 | — | $118.5M | ||
| Q2 24 | — | $118.0M | ||
| Q1 24 | — | $118.2M |
股东权益HVTOFIX
| Q4 25 | $307.9M | $450.0M | ||
| Q3 25 | $306.0M | $442.5M | ||
| Q2 25 | $304.9M | $458.3M | ||
| Q1 25 | $305.4M | $458.3M | ||
| Q4 24 | $307.6M | $503.1M | ||
| Q3 24 | $307.8M | $525.9M | ||
| Q2 24 | $307.1M | $546.0M | ||
| Q1 24 | $306.7M | $570.3M |
总资产HVTOFIX
| Q4 25 | $649.1M | $850.6M | ||
| Q3 25 | $651.7M | $832.6M | ||
| Q2 25 | $642.7M | $837.2M | ||
| Q1 25 | $642.7M | $823.1M | ||
| Q4 24 | $648.7M | $893.3M | ||
| Q3 24 | $659.3M | $867.9M | ||
| Q2 24 | $642.1M | $882.0M | ||
| Q1 24 | $640.5M | $906.0M |
负债/权益比HVTOFIX
| Q4 25 | — | — | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.34× | ||
| Q1 25 | — | 0.34× | ||
| Q4 24 | — | 0.31× | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.22× | ||
| Q1 24 | — | 0.21× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.4M | $27.7M |
| 自由现金流经营现金流 - 资本支出 | $3.0M | $16.8M |
| 自由现金流率自由现金流/营收 | 1.5% | 7.6% |
| 资本支出强度资本支出/营收 | 2.2% | 4.9% |
| 现金转化率经营现金流/净利润 | 0.86× | — |
| 过去12个月自由现金流最近4个季度 | $33.0M | $-1.3M |
8季度趋势，按日历期对齐
经营现金流HVTOFIX
| Q4 25 | $7.4M | $27.7M | ||
| Q3 25 | $31.9M | $12.4M | ||
| Q2 25 | $7.2M | $11.6M | ||
| Q1 25 | $6.2M | $-18.4M | ||
| Q4 24 | $16.9M | $23.7M | ||
| Q3 24 | $24.4M | $11.7M | ||
| Q2 24 | $14.4M | $9.0M | ||
| Q1 24 | $3.1M | $-18.6M |
自由现金流HVTOFIX
| Q4 25 | $3.0M | $16.8M | ||
| Q3 25 | $28.3M | $2.5M | ||
| Q2 25 | $1.6M | $4.5M | ||
| Q1 25 | $27.0K | $-25.1M | ||
| Q4 24 | $9.1M | $15.2M | ||
| Q3 24 | $16.1M | $6.3M | ||
| Q2 24 | $4.9M | $-360.0K | ||
| Q1 24 | $-3.3M | $-29.1M |
自由现金流率HVTOFIX
| Q4 25 | 1.5% | 7.6% | ||
| Q3 25 | 14.6% | 1.2% | ||
| Q2 25 | 0.9% | 2.2% | ||
| Q1 25 | 0.0% | -13.0% | ||
| Q4 24 | 4.9% | 7.0% | ||
| Q3 24 | 9.2% | 3.2% | ||
| Q2 24 | 2.7% | -0.2% | ||
| Q1 24 | -1.8% | -15.4% |
资本支出强度HVTOFIX
| Q4 25 | 2.2% | 4.9% | ||
| Q3 25 | 1.8% | 4.8% | ||
| Q2 25 | 3.1% | 3.5% | ||
| Q1 25 | 3.4% | 3.5% | ||
| Q4 24 | 4.2% | 4.0% | ||
| Q3 24 | 4.7% | 2.7% | ||
| Q2 24 | 5.3% | 4.7% | ||
| Q1 24 | 3.5% | 5.6% |
现金转化率HVTOFIX
| Q4 25 | 0.86× | — | ||
| Q3 25 | 6.75× | — | ||
| Q2 25 | 2.69× | — | ||
| Q1 25 | 1.63× | — | ||
| Q4 24 | 2.06× | — | ||
| Q3 24 | 4.96× | — | ||
| Q2 24 | 3.25× | — | ||
| Q1 24 | 1.31× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HVT
| Upholstery | $91.0M | 45% |
| Bedroom Furniture | $29.2M | 14% |
| Accessories And Other | $28.4M | 14% |
| Dining Room Furniture | $22.8M | 11% |
| Mattresses | $16.1M | 8% |
| Occasional | $14.4M | 7% |
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
